Systemic immunomodulatory effects of Polypodium leucotomos as an adjuvant to PUVA therapy in generalized vitiligo: A pilot study
- 1 March 2006
- journal article
- other
- Published by Elsevier BV in Journal of Dermatological Science
- Vol. 41 (3), 213-216
- https://doi.org/10.1016/j.jdermsci.2005.12.006
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Psoralen ultraviolet A therapy in 2004Photodermatology, Photoimmunology & Photomedicine, 2004
- The risk of melanoma in association with long-term exposure to PUVAJournal of the American Academy of Dermatology, 2001
- Treatment of T Lymphocytes with 8-Methoxypsoralen Plus Ultraviolet A Induces Transient but Biologically Active Th1-Skewing Cytokine ProductionJournal of Investigative Dermatology, 1999
- An extract of Polypodium leucotomos appears to minimize certain photoaging changes in a hairless albino mouse animal model: A pilot studyPhotodermatology, Photoimmunology & Photomedicine, 1999
- Topical or oral administration with an extract of Polypodium leucotomos prevents acute sunburn and psoralen‐induced phototoxic reactions as well as depletion of Langerhans cells in human skinPhotodermatology, Photoimmunology & Photomedicine, 1997
- An extract of the fern Polypodium leucotomos inhibits human peripheral blood mononuclear cells proliferation in vitroInternational Journal of Immunopharmacology, 1997
- PUVA Treatment Selectively Induces a Cell Cycle Block and Subsequent Apoptosis in Human T‐LymphocytesPhotochemistry and Photobiology, 1996
- Inhibition of ultraviolet‐induced formation of reactive oxygen species, lipid peroxidation, erythema and skin photosensitization by Polypodium leucotomosPhotodermatology, Photoimmunology & Photomedicine, 1996